Mologen Appoints Walter Miller CFO
This article was originally published in Scrip
Immunology-focused biotech Mologen AG has appointed Walter Miller chief financial officer (CFO) and to its executive board – effective April 1, 2016. Miller has experience in working at start-ups and listed companies in Germany and abroad and most recently was CFO of Nuvisan GmbH. Prior to this he held various managerial positions at Santhera Pharmaceuticals Group.